• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Biotechnology
  2. Vol 9 (2), 2010
  3. 170-175
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Biotechnology

Year: 2010 | Volume: 9 | Issue: 2 | Page No.: 170-175
DOI: 10.3923/biotech.2010.170.175

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 194

Authors


N. Saleh


M.A. Ibrahim

Country: Jordan

E. Archoukieh


A. Makkiya


M. Al-Obaidi

Country: USA

H. Alobydi

Country: USA

Keywords


  • Leukemia
  • RAPD-PCR analysis
  • genetic polymorphisms
  • DNA markers
Research Article

Identification of Genomic Markers by RAPD-PCR Primer in Leukemia Patients

N. Saleh, M.A. Ibrahim, E. Archoukieh, A. Makkiya, M. Al-Obaidi and H. Alobydi
The aim of this study is to ascertain the possible application of Random Amplification of Polymorphic DNA (RAPD) analysis as a genetic test to investigate DNA polymorphisms and detection of genomic markers in various types of leukemia. The results showed unique profiles of amplified DNA fragments produced in genomic DNA of three types of leukemia by an arbitrary primer of decamer oligonucleotides OPA-09. The primer produced four types of amplified DNA fragments (980, 1659, 2187 and 3162 bp). The smallest amplified DNA fragment (980 bp) appeared in 14.3 and 13.3% of tested acute myeloid leukemia and chronic myeloid leukemia patients, respectively; but was absent in genomic DNA of chronic lymphoid leukemia and normal individuals. Whereas the largest amplified fragment (3162 bp) was present in 12.5, 20 and 75% of chronic lymphoid leukemia, chronic myeloid leukemia and normal individuals, respectively and was absent in acute myeloid leukemia. On the other hand, the two amplified fragments (1659 and 2187 bp) were present in normal and leukemia patients. Cluster analysis of amplified DNA fragments grouped the leukemia patients in two main groups. The detected DNA polymorphisms by the arbitrary primer OPA-09 might find application in developing efficient RAPD primer for diagnosis of leukemia.
PDF Fulltext XML References Citation

How to cite this article

N. Saleh, M.A. Ibrahim, E. Archoukieh, A. Makkiya, M. Al-Obaidi and H. Alobydi, 2010. Identification of Genomic Markers by RAPD-PCR Primer in Leukemia Patients. Biotechnology, 9: 170-175.

DOI: 10.3923/biotech.2010.170.175

URL: https://scialert.net/abstract/?doi=biotech.2010.170.175

Related Articles

Molecular Diagnostics and Therapy of Acute Myeloid Leukemia
Perspective of DNA Methylation in Cancer Research
Prospects for DNA Methylation Research in Psychiatric Disorders
Advances in Genomic DNA Methylation Analysis
Consequences of Chronic Bacterial Infections on Development of Cancer
Molecular Characterization of Pomegranate (Punica granatum L.) Landraces Grown in Jordan using Amplified Fragment Length Polymorphism Markers
Analysis of Genetic Diversity in Bangladeshi Chicken using RAPD Markers
Effectiveness of RAPD Marker in Generating Polymorphism in Different Chicken Population

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved